Review



gene exp cd33 hs01076282 g1  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Thermo Fisher gene exp cd33 hs01076282 g1
    Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
    Gene Exp Cd33 Hs01076282 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd33/Gene+Exp%2E+CD33%2C+Hs01076282_g1/pmc13087446-102-26-2
    Average 94 stars, based on 1 article reviews
    gene exp cd33 hs01076282 g1 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC"

    Article Title: Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

    Journal: Exploration of Targeted Anti-tumor Therapy

    doi: 10.37349/etat.2026.1002365

    Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for CD33 , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
    Figure Legend Snippet: Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for CD33 , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.

    Techniques Used: Expressing

    Urinary microbiome-immune coupling. Matrix plot summarizing associations between immune-related gene expression (PD-L1 , PD-L2 , CD33 , and CD204 ) and microbiome indices, including phylum-level balances (Bal_) and taxon-specific log-abundances (_nb), across all four time points. Colors indicate the direction and magnitude of the mixed-effects model coefficient ( β ), and numbers in each cell show β (two significant digits). Coefficients ( β ) are from linear mixed-effects models with immune transcript levels (ΔCt) as outcomes and microbiome features as predictors, including a random intercept for participant. Taxon-specific features (nb) were entered as clr-transformed abundances (pseudocount = 1), whereas balance indices (Bal) were entered as predefined log-ratio/ilr features; fixed effects included timepoint and available clinical covariates (age, sex, antibiotics, UTI, stage, maintenance BCG). The symbol † indicates associations that met the exploratory false discovery rate threshold (Benjamini–Hochberg adjusted q < 0.10). Bal_ denotes the log-ratio between two taxonomic groups, and _nb denotes the log-abundance of a specific taxon. Bal_inflam = log[P/(F + B)]. P: Proteobacteria; F: Firmicutes; B: Bacteroidetes; A: Actinobacteria; Cory: Corynebacterium ; Staph: Staphylococcus ; Entero: Enterobacteriaceae; BCG: Bacillus Calmette–Guérin; UTI: urinary tract infection. The underlying numerical results ( β , P , and q values) are provided in .
    Figure Legend Snippet: Urinary microbiome-immune coupling. Matrix plot summarizing associations between immune-related gene expression (PD-L1 , PD-L2 , CD33 , and CD204 ) and microbiome indices, including phylum-level balances (Bal_) and taxon-specific log-abundances (_nb), across all four time points. Colors indicate the direction and magnitude of the mixed-effects model coefficient ( β ), and numbers in each cell show β (two significant digits). Coefficients ( β ) are from linear mixed-effects models with immune transcript levels (ΔCt) as outcomes and microbiome features as predictors, including a random intercept for participant. Taxon-specific features (nb) were entered as clr-transformed abundances (pseudocount = 1), whereas balance indices (Bal) were entered as predefined log-ratio/ilr features; fixed effects included timepoint and available clinical covariates (age, sex, antibiotics, UTI, stage, maintenance BCG). The symbol † indicates associations that met the exploratory false discovery rate threshold (Benjamini–Hochberg adjusted q < 0.10). Bal_ denotes the log-ratio between two taxonomic groups, and _nb denotes the log-abundance of a specific taxon. Bal_inflam = log[P/(F + B)]. P: Proteobacteria; F: Firmicutes; B: Bacteroidetes; A: Actinobacteria; Cory: Corynebacterium ; Staph: Staphylococcus ; Entero: Enterobacteriaceae; BCG: Bacillus Calmette–Guérin; UTI: urinary tract infection. The underlying numerical results ( β , P , and q values) are provided in .

    Techniques Used: Gene Expression, Transformation Assay, Infection

    Related Articles

    Expressing:


    Article Title: A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
    Article Snippet: CD33 , CD33 molecule , Hs01076282_g1.

    Article Title: Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
    Article Snippet: , (assay ID: Hs01076282_g1) , Median (IQR) , 0.045 (0.015–0.1) , 0.085 (0.049–0.2) , 0.11 (0.061–0.14) , 0.12 (0.08–0.18) , 0.13 (0.091–0.18) , 0.099 (0.031–0.15) , 0.1 (0.061–0.18) , 0.084 (0.029–0.25) , 0.13 (0.028–0.38).

    Gene Expression:


    Article Title: A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
    Article Snippet: CD33 , CD33 molecule , Hs01076282_g1.

    Article Title: Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
    Article Snippet: , (assay ID: Hs01076282_g1) , Median (IQR) , 0.045 (0.015–0.1) , 0.085 (0.049–0.2) , 0.11 (0.061–0.14) , 0.12 (0.08–0.18) , 0.13 (0.091–0.18) , 0.099 (0.031–0.15) , 0.1 (0.061–0.18) , 0.084 (0.029–0.25) , 0.13 (0.028–0.38).

    Transformation Assay:


    Article Title: A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
    Article Snippet: CD33 , CD33 molecule , Hs01076282_g1.

    Article Title: Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
    Article Snippet: , (assay ID: Hs01076282_g1) , Median (IQR) , 0.045 (0.015–0.1) , 0.085 (0.049–0.2) , 0.11 (0.061–0.14) , 0.12 (0.08–0.18) , 0.13 (0.091–0.18) , 0.099 (0.031–0.15) , 0.1 (0.061–0.18) , 0.084 (0.029–0.25) , 0.13 (0.028–0.38).

    Infection:


    Article Title: A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
    Article Snippet: CD33 , CD33 molecule , Hs01076282_g1.

    Article Title: Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
    Article Snippet: , (assay ID: Hs01076282_g1) , Median (IQR) , 0.045 (0.015–0.1) , 0.085 (0.049–0.2) , 0.11 (0.061–0.14) , 0.12 (0.08–0.18) , 0.13 (0.091–0.18) , 0.099 (0.031–0.15) , 0.1 (0.061–0.18) , 0.084 (0.029–0.25) , 0.13 (0.028–0.38).

    TaqMan Assay:


    Article Title: A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
    Article Snippet: CD33 , CD33 molecule , Hs01076282_g1.

    Article Title: Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
    Article Snippet: , (assay ID: Hs01076282_g1) , Median (IQR) , 0.045 (0.015–0.1) , 0.085 (0.049–0.2) , 0.11 (0.061–0.14) , 0.12 (0.08–0.18) , 0.13 (0.091–0.18) , 0.099 (0.031–0.15) , 0.1 (0.061–0.18) , 0.084 (0.029–0.25) , 0.13 (0.028–0.38).

    Membrane:


    Article Title: A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
    Article Snippet: CD33 , CD33 molecule , Hs01076282_g1.

    Article Title: Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
    Article Snippet: , (assay ID: Hs01076282_g1) , Median (IQR) , 0.045 (0.015–0.1) , 0.085 (0.049–0.2) , 0.11 (0.061–0.14) , 0.12 (0.08–0.18) , 0.13 (0.091–0.18) , 0.099 (0.031–0.15) , 0.1 (0.061–0.18) , 0.084 (0.029–0.25) , 0.13 (0.028–0.38).

    RNA Expression:


    Article Title: A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia
    Article Snippet: CD33 , CD33 molecule , Hs01076282_g1.

    Article Title: Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
    Article Snippet: , (assay ID: Hs01076282_g1) , Median (IQR) , 0.045 (0.015–0.1) , 0.085 (0.049–0.2) , 0.11 (0.061–0.14) , 0.12 (0.08–0.18) , 0.13 (0.091–0.18) , 0.099 (0.031–0.15) , 0.1 (0.061–0.18) , 0.084 (0.029–0.25) , 0.13 (0.028–0.38).



    Similar Products

    99
    NSJ Bioreagents cd33 antibody
    Cd33 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd33/CD33+Antibody/custom%40v2060%4042825054
    Average 99 stars, based on 1 article reviews
    cd33 antibody - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    NSJ Bioreagents cd33 antibody pe conjugate
    Cd33 Antibody Pe Conjugate, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd33/CD33+Antibody+PE+Conjugate/custom%40v2060pe%4042825054
    Average 99 stars, based on 1 article reviews
    cd33 antibody pe conjugate - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results